Pfizer and BioNTech is reportedly seeking emergency use authorization from the Food and Drug Administration for a COVID-19 vaccine booster for all individuals aged 18 years old and older.
The Food and Drug Administration will take the committee’s vote under consideration, and vaccine advisers to the CDC will meet from Nov. 2 to 3 to decide whether to recommend that children get the COVID-19 vaccine.
There are now booster recommendations for all three available COVID-19 vaccines, and eligible individuals may choose which vaccine they receive as a booster dose.